Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Gary Craig Curhan, Sc.D., M.D.

Co-Author

This page shows the publications co-authored by Gary Curhan and Molin Wang.
Connection Strength

1.950
  1. Type 2 diabetes and the risk of incident hearing loss. Diabetologia. 2019 02; 62(2):281-285.
    View in: PubMed
    Score: 0.202
  2. Adherence to Healthful Dietary Patterns Is Associated with Lower Risk of Hearing Loss in Women. J Nutr. 2018 06 01; 148(6):944-951.
    View in: PubMed
    Score: 0.196
  3. Menopause and postmenopausal hormone therapy and risk of hearing loss. Menopause. 2017 Sep; 24(9):1049-1056.
    View in: PubMed
    Score: 0.186
  4. Prospective Study of Gastroesophageal Reflux, Use of Proton Pump Inhibitors and H2-Receptor Antagonists, and Risk of Hearing Loss. Ear Hear. 2017 Jan/Feb; 38(1):21-27.
    View in: PubMed
    Score: 0.178
  5. Duration of Analgesic Use and Risk of Hearing Loss in Women. Am J Epidemiol. 2017 01 01; 185(1):40-47.
    View in: PubMed
    Score: 0.177
  6. Hypertension, Diuretic Use, and Risk of Hearing Loss. Am J Med. 2016 Apr; 129(4):416-22.
    View in: PubMed
    Score: 0.165
  7. Carotenoids, vitamin A, vitamin C, vitamin E, and folate and risk of self-reported hearing loss in women. Am J Clin Nutr. 2015 Nov; 102(5):1167-75.
    View in: PubMed
    Score: 0.163
  8. Prospective study of alcohol consumption and self-reported hearing loss in women. Alcohol. 2015 Feb; 49(1):71-7.
    View in: PubMed
    Score: 0.153
  9. Fish and fatty acid consumption and the risk of hearing loss in women. Am J Clin Nutr. 2014 Nov; 100(5):1371-7.
    View in: PubMed
    Score: 0.152
  10. Body mass index, waist circumference, physical activity, and risk of hearing loss in women. Am J Med. 2013 Dec; 126(12):1142.e1-8.
    View in: PubMed
    Score: 0.142
  11. Renal Outcomes in Medically and Surgically Treated Primary Aldosteronism. Hypertension. 2018 09; 72(3):658-666.
    View in: PubMed
    Score: 0.050
  12. Incidence of Atrial Fibrillation and Mineralocorticoid Receptor Activity in Patients With Medically and Surgically Treated Primary Aldosteronism. JAMA Cardiol. 2018 08 01; 3(8):768-774.
    View in: PubMed
    Score: 0.050
  13. Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort study. Lancet Diabetes Endocrinol. 2018 01; 6(1):51-59.
    View in: PubMed
    Score: 0.047
  14. Body Size and the Risk of Primary Hyperparathyroidism in Women: A Cohort Study. J Bone Miner Res. 2017 Sep; 32(9):1900-1906.
    View in: PubMed
    Score: 0.046
  15. Physical Activity and the Risk of Primary Hyperparathyroidism. J Clin Endocrinol Metab. 2016 04; 101(4):1590-7.
    View in: PubMed
    Score: 0.042
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.